Skip to Content

Integrated Pharmaceuticals Inc INTP

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INTP is trading at a 164% premium.
Price
$0.00
Fair Value
$9.50
Uncertainty
Extreme
1-Star Price
$3.79
5-Star Price
$1.33
Economic Moat
Wkjly
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INTP is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$47.05
Volume/Avg
2,000 / 2,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Integrated Pharmaceuticals Inc is a Filipino-owned pharmaceutical company. Its pharmaceutical product range consits of Analgesic / Antipyretic, Mucolytic, Anti-hypertensive, Anti-gout, Anti-inflammtory, Anti-thrombotic and Anti-diabetic and Antibiotic.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
6

Valuation

Metric
INTP
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
INTP
Quick Ratio
0.51
Current Ratio
1.00
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
INTP
Return on Assets (Normalized)
−147.03%
Return on Equity (Normalized)
−201.84%
Return on Invested Capital (Normalized)
−201.83%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
JbpsncbvjzHxbjdcl$80.3 Bil
Zoetis Inc Class A
ZTS
SyxydqckbMyj$78.2 Bil
Haleon PLC ADR
HLN
YyfslrdpXqc$37.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
LsjrbdhbHqyn$12.1 Bil
Viatris Inc
VTRS
VzrtbzscwBkgj$12.1 Bil
Catalent Inc
CTLT
NwjtcrpZddfsp$10.0 Bil
Perrigo Co PLC
PRGO
MfhlyxqpTmwg$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
ZjbkwxhcJvqdjpl$3.2 Bil
Curaleaf Holdings Inc
CURLF
DvryttyXlg$3.0 Bil
Green Thumb Industries Inc
GTBIF
GqcpdpxwrRnrz$2.7 Bil

Sponsor Center